跳至主要内容
临床试验/CTRI/2025/02/080965
CTRI/2025/02/080965尚未招募不适用

Evaluation of Respiration adjusted shock index (RASI) as a predictor of endotracheal intubation and peri-intubation complications in critically ill patients presenting to Emergency department in a Tertiary care hospital

Dipanjan Halder1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Diagnostic accuracy (Area under curve) of RASI for impending endotracheal intubation

研究概览

简要总结

This study will evaluate the use of the Respiration Adjusted Shock Index (RASI) as a predictor of the need for endotracheal intubation and associated complications in critically ill patients in the emergency department. Patients with hemodynamic instability or those triaged as critical (red) based on WHO or trauma triage criteria will be monitored, assessed, and have RASI calculated if they meet the inclusion criteria. Blood tests, including lactate levels, will be analyzed, and patients will be followed to observe whether intubation is performed. If intubation occurs, the study will document the indications and complications such as peri-intubation hypotension, hypoxic episodes, cardiac arrest, and airway management challenges. Outcomes will be tracked until hospital discharge or mortality.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • Patients with hemodynamic instability and triaged red for immediate need for treatment in emergency department and trauma patients triaged red according to trauma triage criteria.

排除标准

  • Patients who are already intubated from outside
  • Patients prophylactically intubated for airway protection
  • Patients with burn injuries 5.

结局指标

主要结局

Diagnostic accuracy (Area under curve) of RASI for impending endotracheal intubation

时间窗: within 24 hours of emergency admission

次要结局

  • 1. To evaluate the correlation between serum lactate & the incidence of intubation & peri-intubation complication(2. To evaluate the role of RASI as a predictor of peri-intubation complications)

研究者

发起方
Dipanjan Halder
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dipanjan Halder

AIIMS Kalyani

研究点 (1)

Loading locations...

相似试验